JPM recap: Where the money is in biotech, alternative upturn indicators and more

I’m back online after a post-JP Morgan decompression, and I wanted to quickly gather a few thoughts about last week, the state of the industry, being in San Francisco and more. If you joined us at our Endpoints News event, thank you. I’d love to hear what…
Click here to view original post